thena, the prominent DeFi protocol with nearly $1 billion in TVL, is expanding its ecosystem by launching USDe and Athena Shards exclusively on the Injective blockchain.
Athena, the decentralized finance (DeFi) protocol that amassed nearly $1 billion in Total Value Locked (TVL) within a month, has announced its exclusive integration with Injective, a lightning-fast interoperable layer 1 blockchain. This collaboration marks the first integration of Athena outside the Ethereum ecosystem, paving the way for Injective users and the wider IBC community to access USDe, Athena’s synthetic dollar, and participate in the protocol’s Shard campaign.
Athena is making waves in the crypto world with its innovative approach to creating profitable synthetic tokens. USDe, the protocol’s synthetic dollar, offers a censorship-resistant, stable and scalable solution for the digital asset market. Unlike traditional stable assets, USDe is fully secured on-chain and is free to compose on other protocols, relying on advanced technologies like delta hedging and established assets like ETH to maintain its connection to the dollar.
At the heart of the Athena ecosystem is the Internet Bond, a high-yield financial instrument that democratizes investment opportunities and savings concepts. By using staked ETH and derivatives markets, Athena ensures the stability of the USDe peg while generating significant profits, creating a new type of stable asset called the synthetic dollar.
Starting Wednesday, March 6, USDe will be available to Injective users, giving them access to this innovative synthetic dollar. Additionally, through this exclusive collaboration, Injective USDe holders will be eligible to participate in the Athena Shards campaign starting on Monday, March 11th. Athena will allow Injective users to receive shards to hold USDe in their Injective wallets, with users receiving 5x Athena protocol shards (or points) as part of their “Shard Campaign” to encourage community engagement and participation.
The integration between Athena and Injective is made possible by Injective’s implementation of the Ethereum standard EIP712, which allows Ethereum wallets such as MetaMask to seamlessly connect to the Injective network and generate an Injective wallet address automatically associated with an Ethereum wallet address. Athena will use this integration to query the Injective network for Ethereum addresses containing USDe and provide segments to those users in the Athena dApp.
Injective users can access USDe through various dApps built on the blockchain, including Helix, Injective’s leading decentralized exchange. With almost zero fees, Injective’s dApps now serve as the cheapest gateway to earning Athena shards. Users can track their segments directly on Athena by linking their MetaMask wallet linked to their Injective wallet address, with segments updated every 24 hours on the Athena platform.
Keplr users can also participate in Athena’s Shard campaign by importing their Keplr wallet address into a new MetaMask account to receive shards. They can get Helix USDe with their Keplr account and link their new linked MetaMask account to Athena to see their earned shards.
The integration with Athena is an example of the seamless access between Ethereum and Injective, unlocking a wide range of possibilities for both the Injective community and the crypto world at large. With Injective, Ethereum users can directly receive new Ethereum-based assets like USDe with lightning-fast speeds, near-zero fees, while using native Ethereum tools and wallets like MetaMask.
As Athena continues to revolutionize the DeFi landscape with its synthetic dollar and Internet bonds, the exclusive launch of Injective marks an important milestone in the expansion of the protocol beyond the Ethereum ecosystem. This collaboration not only benefits Athena and Injective users, but also demonstrates the growing interoperability and synergy within the broader crypto and blockchain community.
Image source: Shutterstock